Cellpap India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.40 M
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Cellpap India
Cellpap India Private Limited (CIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 July 1995 and has a history of 29 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Kedia and Pradeep Kedia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U67190MH1995PTC127998
-
Company No.
127998
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Cellpap India Private Limited offer?
Cellpap India Private Limited offers a wide range of products and services, including Coated Paper, Silicone Coated Release Liner Paper, Paper & Paper Made Products, Printing Paper, Kraft Paper, Bleached Kraft Paper, Tissue Paper, Facial Tissue Paper.
Who are the key members and board of directors at Cellpap India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Kedia
|
Director | 31-Jul-2000 | Current |
|
Pradeep Kedia
|
Director | 31-Jul-2000 | Current |
Financial Performance of Cellpap India.
Cellpap India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellpap India?
In 2023, Cellpap India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cellpap Recycling LlpPradeep Kedia is a mutual person
-
Cellpap Mercantile LlpPradeep Kedia is a mutual person
-
Nan Trading LlpSaurabh Kedia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cellpap India?
Unlock and access historical data on people associated with Cellpap India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellpap India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellpap India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
